Literature DB >> 15765589

Evaluation of a commercial test based on ligase chain reaction for direct detection of Mycobacterium tuberculosis in respiratory specimens.

Fabíola Karla Corrêa Ribeiro1, Valdério do Valle Dettoni, Renata Lyrio Peres, Solange Alves Vinhas, Tatiana Resende Có, Reynaldo Dietze, Moisés Palaci.   

Abstract

A ligase chain reaction DNA amplification method for direct detection of Mycobacterium tuberculosis (Abbott LCx MTB) in respiratory specimens was evaluated. Results from LCx MTB Assay were compared with those from acid fast bacilli smear, culture, and final clinical diagnosis for each patient. A total of 297 respiratory specimens (sputum and bronchial lavage) from 193 patients were tested. The sensitivity, specificity, positive predictive value and negative predictive value of LC vs culture were 92.7%, 93%, 67.8% and 98.7%, respectively. When compared to the clinical final diagnosis, the sensitivity, specificity, PPV and NPV for LCx were 88.9%, 96.8%, 86.5% and 97.4%, respectively. The sensitivity of LCx MTB assay was 75% for smear-negative, culture positive samples. The results indicate that LCx MTB assay is a rapid, simple and valuable technique as a complementary tool for the diagnosis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15765589     DOI: 10.1590/s0037-86822004000600001

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

1.  Comparison of two laboratory-developed PCR methods for the diagnosis of pulmonary tuberculosis in Brazilian patients with and without HIV infection.

Authors:  Luciene C Scherer; Rosa D Sperhacke; Carla Jarczewski; Patrícia I Cafrune; Candice T Michelon; Rubia Rupenthal; Marta Osorio Ribeiro; Antonio Ruffino Netto; Maria L R Rossetti; Afrânio L Kritski
Journal:  BMC Pulm Med       Date:  2011-03-29       Impact factor: 3.317

Review 2.  Nucleic acid amplification-based techniques for pathogen detection and identification.

Authors:  Paul T Monis; Steven Giglio
Journal:  Infect Genet Evol       Date:  2005-09-19       Impact factor: 3.342

3.  Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Authors:  Daphne I Ling; Laura L Flores; Lee W Riley; Madhukar Pai
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

4.  PCR colorimetric dot-blot assay and clinical pretest probability for diagnosis of Pulmonary Tuberculosis in smear-negative patients.

Authors:  Luciene Cardoso Scherer; Rosa Dea Sperhacke; Carla Jarczewski; Patrícia I Cafrune; Simone Minghelli; Marta Osório Ribeiro; Fernanda Cq Mello; Antonio Ruffino-Netto; Maria Lr Rossetti; Afrânio L Kritski
Journal:  BMC Public Health       Date:  2007-12-20       Impact factor: 3.295

Review 5.  Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation.

Authors:  Francis Drobniewski; Vladyslav Nikolayevskyy; Horst Maxeiner; Yanina Balabanova; Nicola Casali; Irina Kontsevaya; Olga Ignatyeva
Journal:  BMC Med       Date:  2013-08-29       Impact factor: 8.775

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.